| SVFs | Stromal Vascular Fraction Cells |
| ASCs | Adipose-Derived Stem Cells |
| SVF | Stromal Vascular Fraction |
| ISCT | International Society for Cellular Therapy |
| MSCs | Mesenchymal Stem Cells |
| HAT | Human Adipose Tissue |
| COVID-19 | Coronavirus Disease 2019 |
| UC | Umbilical-Cord |
| BM | Bone-Marrow |
| BM-MSCs | Bone-Marrow MSCs |
| UC-MSCs | Umbilical-Cord MSCs |
| AD | Adipose Tissue |
| AD-MSCs | Adipose-Derived Mesenchymal Stem Cells |
| ECM | Extracellular Matrix |
| FDA | Food and Drug Administration |
| EMA | European Medical Agency |
| CAT | Committee for Advanced Therapies |
| EC | European Parliament |
| GMP | Good Manufacturing Practices |
| GCP | Good Clinical Practices |
| sCTMP | Somatic Cell Therapy Medicines |
| TEP | Tissue Engineering products |
| ATMPs | Advanced Therapy Medicinal Products |
| STROBE | Strengthening the Reporting of Observational Studies in Epidemiology |
| PRISMA | Preferred Reporting for Items for Systematic Reviews and Meta-Analyses |
| EBM | Evidence-Based Medicine |
| OCEBM | Oxford Centre for Evidence-Based Medicine |
| ARDS | Acute Respiratory Distress Syndrome |
| haMPCs | allogenic human Adipose-Derived Mesenchymal Progenitor Cells |
| e-ASC | expanded Adipose-derived Stem Cells |
| RA | Rheumatoid Arthritis |
| OA | Osteoarthritic |
| e-a-MSCs | expanded-allogenic Mesenchymal Stem Cells |
| CSCC_ASC | Cardiology Stem Cell Centre Adipose-derived Stromal Cell |
| IHF | Ischemic Heart Failure |
| GvHD | Graft-versus-Host disease |
| ADSCs | Adipose-derived Stromal Cells |
| NRVMs | Neonatal Rat Ventricular Myocytes |
| HC | Hypertrophic cartilage |
| LE | Lateral Epicondylosis |
| VAS | Visual Analog Scale |
| LPS | Lipopolysaccharide |